Petra Pharma Competitors and Similar CompaniesClear all

Petra Pharma's competitors and similar companies include Scynexis, Azafaros and CStone Pharmaceuticals.
Petra Pharma
Petra Pharma
Petra Pharma is a drug development company focused on therapies for serious medical conditions such as cancer and metabolic diseases.
Scynexis
Scynexis
Scynexis is engaged in drug discovery, development and manufacturing projects in various areas.
Azafaros
Azafaros
Azafaros is a medical drug development company intended to provide assistance for the treatment of rare metabolic disorders.
CStone Pharmaceuticals
CStone Pharmaceuticals
CStone Pharmaceuticals is a biopharmaceutical company devoted to the development of a new generation of innovative drugs.
Founding Date
Founding Date
2016
Founding Date
2000
Founding Date
2018
Founding Date
2016
Type
Type
Subsidiary
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
New York, US HQ
Locations
Jersey City, US HQ
Locations
Leiden, NL HQ
Southport, AU
Basel, CH
Locations
Suzhou, CN HQ
Beijing, CN
Shanghai, CN
Employees
Employees
20
Employees
3636% decrease
Employees
215% decrease
Employees
1932% decrease

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 27.5m (over 6 years ago)
Latest funding round
$ 260m (about 8 years ago)
Total funding raised
Total funding raised
$ 48m
Total funding raised
$ 11.5m
Total funding raised
$ 27.5m
Total funding raised
$ 410m
For sources of this data, please see the company profile

View Company Profiles

Scynexis
HQ
Jersey City, US
Employees
36↓ 36% decrease

Scynexis is engaged in drug discovery, development and manufacturing projects in various areas.

View company
Azafaros
HQ
Leiden, NL
Employees
21↓ 5% decrease

Azafaros is a medical drug development company intended to provide assistance for the treatment of rare metabolic disorders.

View company
CStone Pharmaceuticals
HQ
Suzhou, CN
Employees
193↓ 2% decrease

CStone Pharmaceuticals is a biopharmaceutical company devoted to the development of a new generation of innovative drugs.

View company